On September 19, 2025, the Food and Drug Administration approved pembrolizumab and berahyaluronidase alfa-pmph (Keytruda Qlex, Merck) for subcutaneous injection…
Compounders sometimes produce drugs using bulk drug substances or active pharmaceutical ingredients. Because compounding from these substances presents risks to…
Potential biomarkers revealed by a metabolomics study were identified in racehorse urine, using chemical and biochemical orthogonal methods, for anabolic…
Potential biomarkers revealed by a metabolomics study were identified in racehorse urine, using chemical and biochemical orthogonal methods, for anabolic…